To verify the clinical significance of RRM2 in glioma patients, firstly, we performed IHC staining analysis, and founded that compared with normal human brain tissues, RRM2, CDK1, and p62 protein expression had increase in distinct grades of glioma, especially in GBM tissues (Figure 7A). Here, RRM2 is linked to central nervous system cancer.